Legal Representation
Attorney
Aaron D. Hendelman
USPTO Deadlines
Next Deadline
58 days remaining
Abandonment Notice E-Mailed - Failure to Respond
Due Date
February 28, 2026
Application History
12 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 29, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Dec 29, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Sep 10, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 10, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 10, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 10, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 16, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 16, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jul 16, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jul 11, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 15, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Apr 15, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Assays for research purposes
Class 005
Medical diagnostic reagents and assays for testing of bodily fluids; medical diagnostic assays for bodily fluid testing for diagnosing Alzheimer’s disease, neurological conditions, auto-immune diseases, and cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Alzheimer’s disease, neurological conditions, auto-immune diseases, and cancer
Class 010
Medical test kits for taking samples and ordering and review of laboratory tests for Alzheimer’s disease, neurological conditions, auto-immune diseases, and cancer
Class 042
Medical laboratory services; providing scientific analysis and information regarding the results of laboratory testing in the fields of Alzheimer’s disease, neurological conditions, auto-immune diseases, and cancer; providing medical research information regarding results of testing for Alzheimer’s disease, neurological conditions, auto-immune diseases, and cancer; medical and scientific research in relation to Alzheimer’s disease, neurological conditions, auto-immune diseases, and cancer; providing medical and scientific research information in the field of disease detection and clinical trials
Classification
International Classes
001
005
010
042